Entero Healthcare Solutions Limited (IN:ENTERO)
:ENTERO
Want to see IN:ENTERO full AI Analyst Report?
ENTERO Stock Chart & Stats
₹1154.55
-₹7.15(-0.49%)
At close: 4:00 PM EST
₹1154.55
-₹7.15(-0.49%)
Day’s Range― - ―
52-Week Range₹944.00 - ₹1,509.90
Previous CloseN/A
Volume53.16K
Average Volume (3M)6.57K
Market Cap
₹58.87B
Enterprise Value₹62.60B
Total Cash (Recent Filing)₹3.49B
Total Debt (Recent Filing)₹4.43B
Price to Earnings (P/E)40.4
Beta0.69
Next Earnings
Aug 19, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)25.41
Shares Outstanding43,510,937
10 Day Avg. Volume6,792
30 Day Avg. Volume6,572
Financial Highlights & Ratios
PEG Ratio0.52
Price to Book (P/B)2.91
Price to Sales (P/S)0.99
P/FCF Ratio-54.79
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)44.48
Revenue Forecast (FY)₹81.39B
Bulls Say, Bears Say
Bulls Say
Business Model / Distribution NetworkEntero’s core distribution and managed-services model creates recurring, transaction-driven revenue from pharmacies, hospitals and manufacturers. Durable demand for pharmaceutical logistics and inventory services supports steady throughput, sticky customer relationships, and scale benefits that underpin long-term revenue resilience.
Revenue Growth And ScaleMaterial multi-year revenue scaling implies expanding market penetration and higher volumes handled. Sustained top-line growth improves bargaining leverage with suppliers, spreads fixed logistics costs across more volume, and creates a base for upselling supply-chain services that can raise lifetime customer value over 2-6 months and beyond.
Improved Balance Sheet / Lower LeverageLower leverage and a stronger equity base reduce refinancing and solvency risk, giving management flexibility to invest in warehousing and tech or absorb working-capital swings. A healthier balance sheet supports strategic partnerships and long-term contracts that are critical for durable distribution economics.
Bears Say
Cash Generation WeaknessConsistent negative operating and free cash flow shows accounting profits aren’t translating to liquidity. For a working-capital intensive distributor, this raises structural funding and liquidity risk, may force recurring external financing, and constrains the firm’s ability to invest in scale or absorb margin pressure sustainably.
Margin Sustainability / VolatilityThin, volatile gross margins increase earnings sensitivity to pricing, supplier terms and cost inflation. As a distributor with limited product differentiation, sustained margin compression could quickly erode profitability and undermine returns on invested capital, making earnings less durable absent clear pricing power or efficiency gains.
Earnings Quality / Funding NeedsThe disconnect between reported profitability and persistent cash burn weakens earnings quality. Until cash conversion improves, reported net income may be fragile and recurring financing needs could dilute returns, limit strategic initiatives, and increase vulnerability to macro or industry funding shocks over the medium term.
Entero Healthcare Solutions Limited News
ENTERO FAQ
What was Entero Healthcare Solutions Limited’s price range in the past 12 months?
Entero Healthcare Solutions Limited lowest stock price was ₹944.00 and its highest was ₹1509.90 in the past 12 months.
What is Entero Healthcare Solutions Limited’s market cap?
Entero Healthcare Solutions Limited’s market cap is ₹58.87B.
When is Entero Healthcare Solutions Limited’s upcoming earnings report date?
Entero Healthcare Solutions Limited’s upcoming earnings report date is Aug 19, 2026 which is in 84 days.
How were Entero Healthcare Solutions Limited’s earnings last quarter?
Entero Healthcare Solutions Limited released its earnings results on May 25, 2026. The company reported ₹6.4 earnings per share for the quarter, missing the consensus estimate of ₹9.1 by -₹2.7.
Is Entero Healthcare Solutions Limited overvalued?
According to Wall Street analysts Entero Healthcare Solutions Limited’s price is currently Overvalued.
Does Entero Healthcare Solutions Limited pay dividends?
Entero Healthcare Solutions Limited does not currently pay dividends.
What is Entero Healthcare Solutions Limited’s EPS estimate?
Entero Healthcare Solutions Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Entero Healthcare Solutions Limited have?
Entero Healthcare Solutions Limited has 43,510,937 shares outstanding.
What happened to Entero Healthcare Solutions Limited’s price movement after its last earnings report?
Entero Healthcare Solutions Limited reported an EPS of ₹6.4 in its last earnings report, missing expectations of ₹9.1. Following the earnings report the stock price went up 0.085%.
Which hedge fund is a major shareholder of Entero Healthcare Solutions Limited?
Currently, no hedge funds are holding shares in IN:ENTERO
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Entero Healthcare Solutions Limited
Entero Healthcare Solutions Limited engages in the trading of pharmaceutical and surgical products to retail pharmacies, hospitals, nursing homes, and healthcare clinics in India. It is involved in the distribution of medical devices, over the counter medical products, nutraceuticals, and vaccines. The company was incorporated in 2018 and is based in Mumbai, India.
Technical Analysis
HealthCare Global Enterprises Ltd.
―
Medi Assist Healthcare Services Limited
―
Panacea Biotec Limited
―
Thyrocare Technologies Ltd
―
Yatharth Hospital and Trauma Care Services Limited
―